Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SORAFENIB vs SPARSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SORAFENIB vs SPARSENTAN: Safety Overview

Metric SORAFENIB SPARSENTAN
Total FAERS Reports 10,908 3,280
Deaths Reported 2,489 18
Death Rate 22.8% 0.5%
Hospitalizations 3,547 209
Average Patient Age 61.1 yrs 49.3 yrs
% Female Patients 29.5% 43.8%
FDA Approval Date Apr 12, 2023 Feb 17, 2023
Manufacturer Upsher-Smith Laboratories, LLC Travere Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription